tiprankstipranks
Takeda Pharmaceutical Co Ltd (JP:4502)
:4502
Japanese Market
4502
Takeda Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4502 full AI Analyst Report?

Takeda Pharmaceutical Co (4502) Income Statement

8 Followers

Takeda Pharmaceutical Co Income Statement

Last quarter (Q4 2025), Takeda Pharmaceutical Co's total revenue was ¥1.09T, an increase of 3.91% from the same quarter last year. In Q4, Takeda Pharmaceutical Co's net income was ¥-24.32B. See Takeda Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 4.51T¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T
Gross Profit
¥ 2.30T¥ 2.46T¥ 2.32T¥ 2.30T¥ 2.04T
Operating Expenses
¥ 1.76T¥ 1.83T¥ 1.79T¥ 1.64T¥ 1.43T
Depreciation and Amortization
¥ 721.13B¥ 761.40B¥ 728.00B¥ 664.40B¥ 583.15B
EBITDA
¥ 1.26T¥ 1.13T¥ 927.95B¥ 1.18T¥ 1.04T
Operating Income
¥ 540.45B¥ 627.54B¥ 531.42B¥ 658.29B¥ 610.50B
Other Income/Expenses
¥ -280.26B¥ -452.46B¥ -478.63B¥ -283.20B¥ -307.93B
Pretax Income
¥ 260.19B¥ 175.08B¥ 52.79B¥ 375.09B¥ 302.57B
Net Income
¥ 191.76B¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B
Per Share Metrics
Basic EPS
¥ 121.75¥ 68.36¥ 92.09¥ 204.29¥ 147.14
Diluted EPS
¥ 119.64¥ 67.23¥ 91.16¥ 201.94¥ 145.87
Weighted Average Shares Outstanding
 1.58B 1.58B 1.56B 1.55B 1.56B
Weighted Average Shares Outstanding (Diluted)
 1.60B 1.61B 1.58B 1.57B 1.58B
Currency in JPY

Takeda Pharmaceutical Co Earnings and Revenue History